EXPLORE A TOPIC
Research and resources to help you take a closer look.
The resource library
3 resourcesThis article examines the core research questions that differentiate small molecule and peptide drug candidates, focusing on their discovery, optimization, and development challenges. Evidence from recent reviews is used to clarify how these questions shape experimental design and translational hurdles.
Therapeutic peptide development requires rigorous evaluation of stability, selectivity, delivery, and manufacturing. This review details the scientific approaches used to assess these properties, distinguishing between approved medicines and research-use products. We examine analytical, biochemical, and technological strategies, highlight advances and limitations, and clarify the boundaries between research findings and clinical application.
Peptides are short chains of amino acids, typically containing 2–50 residues, while proteins are longer, often with complex three-dimensional structures. Both play crucial roles in biological signaling, but peptides’ smaller size gives them unique properties and research applications. Peptide research is foundational for understanding biology and drug development, but does not establish safety or efficacy for consumer products without rigorous clinical trials.
